New devices less effective in thwarting brain aneurysm recurrence

A retrospective analysis of 100 patients suffering from a ruptured brain aneurysm has found that expensive new coiling devices are no more effective than bare platinum coils at preventing aneurysms from recurring.

A team of researchers from the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital, led by Andrew Ringer, MD, evaluated the risk of intracranial aneurysm recurrence after endovascular treatment with each of three different kinds of coils.

Ringer, the study’s principal investigator, is a neurosurgeon with the Mayfield Clinic and is director of endovascular neurosurgery and associate professor of neurosurgery at UC.

The findings are being presented at the International Stroke Conference this week in New Orleans.

An intracranial aneurysm is a balloon-like bulge or blister on an artery in the brain. Aneurysms with thin necks, known as saccular aneurysms, are often treated with a clip. During a craniotomy, a procedure in which the skull is surgically opened, a neurosurgeon places the clip across the neck of the aneurysm, shutting off the aneurysm’s blood supply.

Surgeons also can use a minimally invasive procedure to treat saccular aneurysms through coiling. A catheter is inserted into an artery in the groin and threaded up through the body to the brain, and a tiny coil is discharged directly into the aneurysm. The minimally invasive procedure enables the patient to avoid surgery and the risks associated with opening the skull.

In an important drawback, however, coils may occasionally compact within the aneurysm. When compaction occurs, blood flows back into the aneurysm, making repeated treatment necessary.

“Companies have tried to address the issue of recurrence after coiling by engineering coils using one of two different approaches,” Ringer says. “One is coated with a polymer designed to promote tissue healing at the neck (opening) of the aneurysm, and one is coated with a gel that, when exposed to blood, is designed to expand inside the aneurysm to fill all the nooks and crannies.

“The purpose of our study was to assess the effectiveness of these new treatments,” Ringer continues. “We found that neither of these newer—and more costly—coils performed any better than the bare platinum coils.”

To determine whether the new strategies posed an improvement, Ringer and his research team analyzed the outcomes during a 3 ½-year period of 100 successively treated patients who had suffered ruptured aneurysms of medium size (five to 15 millimeters in diameter).

At the end of one year, the bare platinum coils were associated with the least number of repeated treatments. The percentage requiring repeated treatment was 6.4 percent in the platinum coils group, 11.5 percent in the expanding gel-coating group, and 20.9 percent in the polymer-coating group.

The results, Ringer says, “suggest the possibility that a factor, or factors, other than coil-surface coating may be responsible for reducing aneurysm recurrence.”

Source: University of Cincinnati

Related stories:

Will screening for aortic aneurysm be effective?
Pilot screening programmes for abdominal aortic aneurysms in men aged 65 are due to be launched in England this year, but is this move too hasty? Two experts debate the issue in this week's BMJ.
Smokers treated for brain aneurysm with coils at higher risk of recurrence
Cigarette smokers who were treated for cerebral aneurysms with coil embolization (blocking of a blood vessel) are at greater risk of developing another aneurysm, say neurological surgeons at Jefferson Hospital for Neuroscience in Philadelphia in the first-known study of its kind.
A strange case of upper obstructive syndrome
Aorto-duodenal fistulae (ADF) are the most frequent aorto-enteric fistulae (80%) and the most frequent presenting sign of ADF is upper gastrointestinal bleeding (UGI). A 59-year-old male patient, who underwent an aortic-bi-femoral bypass five years ago, was admitted to the Emergency Room after five days of persistent occlusive syndrome with dyspepsia and biliary vomiting.
Study analyzes best approach for treating abdominal aortic aneurysms
Abdominal aortic aneurysm (AAA)—a condition in which the large vessel that supplies blood to your abdomen, legs, and pelvis swells to over 50 percent its normal size—occurs in approximately 4 out of 100 adults. The risk increases with age, peaking after age 70. AAA is more common in men than women, and more common in smokers or former smokers than those who never smoked. If the aneurysm ruptures, most patients die before they even get to the hospital.
Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
Neurological surgeons at Jefferson Hospital for Neuroscience are among the first surgeons in the United States using an FDA-approved liquid system for treating wide-necked brain aneurysms, which could eventually replace current treatments.
Life-threatening gene defect located by UT-Houston researchers
A research team led by scientists at The University of Texas Medical School at Houston has identified a defective gene that affects vascular smooth-muscle cells in people who suffer from hereditary thoracic aortic disease, which can kill victims with little warning in the prime of their lives.
Preclinical study links gene to brain aneurysm formation
University of Cincinnati (UC) neurovascular researchers have identified a gene that—when suppressed or completely absent—may predispose a person to brain aneurysms.
Study suggests other causes for childhood brain aneurysms
A new University of Cincinnati (UC) study questions the commonly held scientific belief that childhood brain aneurysms are caused by trauma, infection or underlying vascular malformations.

News discussion:

Medicine & Health news